Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAnxiety is not listed as a common side effect of Mounjaro in its UK prescribing information, but some people starting tirzepatide do report feeling unsettled, jittery, or more anxious than usual, particularly in the first few weeks. The reasons are usually indirect (blood-sugar shifts, disrupted sleep, or the body adjusting to reduced food intake) rather than a direct pharmacological effect on mood. Mounjaro (tirzepatide) is a prescription-only medicine requiring clinical assessment before it can be prescribed; a GPhC-registered Independent Prescriber reviews every consultation at nume, so any concerns about existing anxiety or mental health are considered before treatment starts.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is no — not in the way nausea or constipation are. Looking at the Mounjaro UK Summary of Product Characteristics, anxiety does not appear among the common, uncommon, or frequently reported adverse reactions. The side-effect profile is led firmly by the gastrointestinal effects: nausea, diarrhoea, vomiting, constipation, and indigestion are the ones most people encounter, particularly around dose increases. You can read the full adverse reaction profile on the NHS tirzepatide medicines page.
That said, the absence from the list does not mean nobody experiences it. Clinical trials capture events that occur statistically more often in the treatment group than placebo. Individual responses can differ. What matters is understanding why some people feel anxious on Mounjaro, because the mechanism usually points to something manageable rather than a fundamental incompatibility with the medicine.
If you want to explore the broader picture of how Mounjaro's side effects present and how long they tend to last, that resource covers the full profile in more detail.
There are several plausible indirect routes. First, blood-glucose fluctuations. Tirzepatide slows gastric emptying and suppresses appetite meaningfully. If someone eats much less than usual without adjusting the timing or composition of meals, they may experience a drop in blood sugar that produces shakiness, racing heart, and a sense of dread that feels indistinguishable from anxiety. This is especially relevant in the first few weeks, when appetite suppression can be abrupt.
Second, sleep. Many people notice changes to their sleep pattern on GLP-1 and dual-agonist medicines, including vivid dreams or lighter sleep. Poor sleep reliably worsens anxiety; the connection between Mounjaro and sleep disturbances is a question that comes up regularly among people starting treatment.
Third, the psychological context of starting a new medicine for weight management is not trivial. People often begin with high expectations, sometimes alongside long-standing anxiety about their weight or health. That pre-existing backdrop can amplify ordinary bodily sensations into something that reads as anxiety.
A fourth, less common possibility is caffeine or stimulant sensitivity. Mounjaro slows the rate at which the stomach empties, which means caffeine from a morning coffee absorbed differently, staying in your system longer than you expect. The practical fix is to pay attention to whether your usual two cups now feel like four.
For most people, the unsettled feeling settles once the body adjusts to the new appetite and blood-sugar rhythm. Symptoms tied to the adjustment period tend to ease within a few weeks, consistent with the broader pattern of how quickly Mounjaro side effects resolve. Eating regular small meals with adequate protein, staying hydrated, and reducing caffeine temporarily can help smooth the transition.
There are, however, situations that warrant prompt contact with your prescriber rather than waiting it out. Contact them if: you experience persistent or worsening anxiety that is affecting daily life; you have thoughts of self-harm or notice a significant shift in your mental wellbeing; the feelings arrived at the same time as other symptoms such as severe abdominal pain (which should prompt emergency care); or if you have a history of an anxiety disorder and feel that Mounjaro is aggravating it. Your prescriber can consider whether a slower titration, a dose pause, or a referral is appropriate. The detailed guide to anxiety-related side effects on Mounjaro covers the escalation steps clearly.
The MHRA also reminds patients that any suspected side effect, including psychological ones, can be reported through the Yellow Card scheme, this contributes to the ongoing safety monitoring of newer medicines including tirzepatide, which currently carries Black Triangle status in the UK.
A pre-existing anxiety condition does not automatically rule out treatment with tirzepatide. The decision sits entirely with a GPhC-registered prescriber who can weigh your mental health history, your current medications, and your overall clinical picture. Certain antidepressants and anxiolytics, for example, may be affected by delayed gastric emptying; your prescriber needs to know about every medicine you take. You can read more about how existing anxiety interacts with Mounjaro from a clinical standpoint.
If you are considering starting treatment and have questions about how tirzepatide might fit alongside your mental health, the consultation at nume is the right place to raise them. A real prescriber reads every submission and considers those details before any approval is given. The cost of treatment includes that clinical review as standard, there is no separate fee for taking the time to get it right.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.